本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aura Biosciences, Inc.

5.76
+0.05000.88%
盘后5.950.1900+3.30%17:12 EDT
成交量:15.88万
成交额:91.39万
市值:2.89亿
市盈率:-3.29
高:5.92
开:5.86
低:5.64
收:5.71
数据加载中...
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/04

重要事件披露

8-K - Current report
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

重要事件披露

8-K - Current report
2023/02/16

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

重要事件披露

8-K - Current report
2022/12/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership